SCHEMBL5458381

SCHEMBL5458381

COc1ccccc1NC(=O)Nc1ccc(C2=CCN(C(=O)Nc3ncccc3C#N)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 5/20 0.48
MAPT P10636 5/20 0.46
PIK3R1 P27986 1/20 0.46
PIK3CA P42336 1/20 0.46
GFER P55789 1/20 0.45
NPC1 O15118 7/20 0.44
RAB9A P51151 7/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 3/20 0.44
ALOX15 P16050 2/20 0.44
HPGD P15428 1/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
THRB P10828 1/20 0.44
TSHR P16473 2/20 0.43
IDO1 P14902 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5454328 0.92 IDO1 (0.46) NAMPTMAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL5469430 0.89 NAMPT (0.47) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5473690 0.89 GFER (0.60) NAMPTMAPTGFERNPC1RAB9A
SCHEMBL5456914 0.88 ALDH1A1 (0.48) NAMPTMAPTPIK3R1PIK3CANPC1
SCHEMBL5456044 0.82 GFER (0.46) MAPTGFERNPC1RAB9ASMN1; SMN2
SCHEMBL5460590 0.81 MAPT (0.52) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5462735 0.81 GFER (0.48) NAMPTMAPTGFERNPC1RAB9A
SCHEMBL5460612 0.79 TRPV1 (0.48) NAMPTMAPTRAB9ASMN1; SMN2ALDH1A1
SCHEMBL5460127 0.79 MAPT (0.47) NAMPTMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL5466920 0.79 RAB9A (0.56) NAMPTMAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 NAMPT 324/4885MAPT 758/4885PIK3R1 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.